Eculizumab in chemotherapy-induced thrombotic microangiopathy

Thrombotic microangiopathy (TMA) is a rare but severe complication of tumors and their chemotherapeutic treatment. We report on two patients with chemotherapy-induced TMA who were successfully treated with a short course of the terminal complement inhibitor eculizumab. Both patients quickly achieved...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulte-Kemna, Lena, Reister, Barbara, Bettac, Lucas, Ludwig, Ulla, Fürst, Daniel, Mytilineos, Joannis, Bergmann, Carsten, van Erp, Rene, Schröppel, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171698/
https://www.ncbi.nlm.nih.gov/pubmed/32318323
http://dx.doi.org/10.5414/CNCS109836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171698/
https://www.ncbi.nlm.nih.gov/pubmed/32318323
http://dx.doi.org/10.5414/CNCS109836

Ejemplares similares